Page last updated: 2024-08-17

dehydroepiandrosterone and regorafenib

dehydroepiandrosterone has been researched along with regorafenib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hammock, BD; Kim, J; Ulu, A; Wan, D; Weiss, RH; Yang, J	1

Other Studies

1 other study(ies) available for dehydroepiandrosterone and regorafenib

Article	Year
Addition of DHA Synergistically Enhances the Efficacy of Regorafenib for Kidney Cancer Therapy. Molecular cancer therapeutics, 2016, Volume: 15, Issue:5 Topics: Animals; Antimetabolites, Antineoplastic; Biomarkers; Cell Line, Tumor; Cytochrome P-450 Enzyme System; Dehydroepiandrosterone; Disease Models, Animal; Drug Synergism; Endothelial Cells; Humans; Kidney Neoplasms; Mice; Models, Molecular; Neovascularization, Pathologic; Phenylurea Compounds; Pyridines; Tumor Burden; Xenograft Model Antitumor Assays	2016

Article

Year

Addition of DHA Synergistically Enhances the Efficacy of Regorafenib for Kidney Cancer Therapy.

Molecular cancer therapeutics, 2016, Volume: 15, Issue:5

Topics: Animals; Antimetabolites, Antineoplastic; Biomarkers; Cell Line, Tumor; Cytochrome P-450 Enzyme System; Dehydroepiandrosterone; Disease Models, Animal; Drug Synergism; Endothelial Cells; Humans; Kidney Neoplasms; Mice; Models, Molecular; Neovascularization, Pathologic; Phenylurea Compounds; Pyridines; Tumor Burden; Xenograft Model Antitumor Assays

2016